FindTrial
Sign In

Predictive Value of the 5-Factor Modified Frailty Index for Major Postoperative Complications in Esophageal Cancer Patients Undergoing Neoadjuvant Therapy

Predictive Value of the 5-Factor Modified Frailty Index for Major Postoperative Complications in Esophageal Cancer Patients Undergoing Neoadjuvant Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107377
Enrollment
Unknown
Registered
2025-08-11
Start date
2025-08-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Frailty group:None
Non-frailty group:None

Sponsors

The First Affiliated Hospital , Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed with esophageal cancer per the Clinical Practice Guidelines for Esophageal Carcinoma and underwent curative-intent esophagectomy with pathological confirmation; 2.Aged >18 years; 3.Completed neoadjuvant therapy followed by scheduled esophageal cancer surgery.

Exclusion criteria

Exclusion criteria: 1.Patients undergoing palliative resection or emergency surgery; 2.Patients with concurrent other malignant tumors; 3.Patients with incomplete clinical data or loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Complication rate;—

Countries

China

Contacts

Public ContactMei Xia

The First Affiliated Hospital , Army Medical University

xiamei@tmmu.edu.cn+86 138 0834 1125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026